AHG (Akso Health Group) Marketable Securities: $0.00 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AHG Akso Health Group AHG
37 GF Score
Price $1.53
GF Value $0.47
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Akso Health Group Marketable Securities?

Akso Health Group AHG 37 Marketable Securities is $0.00 Mil as of Sep. 2025. GuruFocus rates AHG with a GF Score™ of 37/100 and a GF Value™ of $0.47 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Akso Health Group's Marketable Securities for the quarter that ended in Sep. 2025 was $0.00 Mil.

Akso Health Group  (NAS:AHG) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Akso Health Group Marketable Securities Related Terms

Akso Health Group Marketable Securities Historical Data

* Premium members only.

The historical data trend for Akso Health Group's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akso Health Group Marketable Securities Chart

Akso Health Group Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Akso Health Group Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AHG
37GF Score
Akso Health Group AHG
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akso Health Group Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Akso Health Group (AHG) has a Marketable Securities of $0.00 Mil as of Sep. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Akso Health Group and its competitors.
Is Akso Health Group's Marketable Securities too high?
Akso Health Group's current Marketable Securities is $0.00 Mil. Overall, Akso Health Group has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Akso Health Group's Marketable Securities compare to ACH and FOCL?
Akso Health Group's Marketable Securities of $0.00 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Distribution company?
A good Marketable Securities depends on the Medical Distribution industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Akso Health Group and its competitors. Akso Health Group's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akso Health Group stock overvalued right now?
Based on GuruFocus' analysis, Akso Health Group (AHG) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.47, compared to a current price of $1.53 — trading 225.5% above its estimated fair value. The current Marketable Securities is $0.00 Mil. Akso Health Group's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Akso Health Group (AHG), the current Marketable Securities is $0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Akso Health Group (AHG) Overvalued in 2026?

Based on GuruFocus' analysis, Akso Health Group stock appears to be overvalued. The current stock price of $1.53 is trading 225.5% above its estimated GF Value™ of $0.47. GuruFocus considers Akso Health Group to be Significantly Overvalued.

Key valuation signals for AHG:

  • Marketable Securities: $0.00 Mil
  • GF Value™: $0.47 vs. price of $1.53 (225.5% above fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the AHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Akso Health Group Business Description

Address No. 44, Moscow Road, Qianwan Bonded Port Area, Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building, Qingdao Pilot Free Trade Zone, Shandong, CHN
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
37GF Score

Get the complete analysis for AHG

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.53
Price
$0.47
GF Value